Medicure Inc. (CVE:MPH – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$1.01 and traded as low as C$0.98. Medicure shares last traded at C$0.98, with a volume of 1,506 shares traded.
Medicure Stock Down 1.0 %
The company has a market cap of C$10.23 million, a P/E ratio of -3.92 and a beta of 0.90. The stock has a 50-day moving average of C$0.93 and a 200 day moving average of C$1.01. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.87 and a quick ratio of 1.29.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- The Basics of Support and Resistance
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
